Earnings Scheduled For May 5, 2022
Companies Reporting Before The Bell
• Mirum Pharmaceuticals (NASDAQ:MIRM) is expected to report quarterly loss at $1.34 per share on revenue of $8.46 million.
Stocks That Hit 52-Week Lows On Wednesday
Wednesday's session saw 784 companies set new 52-week lows.
Sidoti & Co. Maintains Buy on DMC Glb, Lowers Price Target to $41
Sidoti & Co. analyst Marisa Hernandez maintains DMC Glb (NASDAQ:BOOM) with a Buy and lowers the price target from $55 to $41.
Stocks That Hit 52-Week Lows On Tuesday
During Tuesday's trading, 98 companies set new 52-week lows.
Recap: DMC Glb Q4 Earnings
DMC Glb (NASDAQ:BOOM) reported its Q4 earnings results on Thursday, February 24, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
Earnings
DMC Glb beat estimated earnings by 150.0%, reporting an EPS of $0.05 versus an estimate of $0.02.
10 Biggest Price Target Changes For Thursday
Barclays lifted the price target on Cintas Corporation (NASDAQ: CTAS) from $470 to $500. Cintas shares rose 1.2% to $434.11 in pre-market trading.
Stifel Maintains Buy on DMC Glb, Raises Price Target to $48
Stifel analyst Stephen Gengaro maintains DMC Glb (NASDAQ:BOOM) with a Buy and raises the price target from $46 to $48.
Sidoti & Co. Upgrades DMC Glb to Buy, Announces $52 Price Target
Sidoti & Co. analyst Edward Marshall upgrades DMC Glb (NASDAQ:BOOM) from Neutral to Buy and announces $52 price target.